NCT03419650View on ClinicalTrials.gov

Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)

PHASE4CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

August 25, 2021

Study Completion Date

August 25, 2021

Conditions

Psoriatic Arthritis

Interventions

DRUG

ACTHar

Acthar™ 80 units twice a week for 4 weeks followed by 40 units twice a week until week 12.

Trial Locations (1)

33324

IRIS Research and Development, Plantation

Sponsors

Lead Sponsor

IRIS Research and Development, LLC

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

IRIS Research and Development, LLC

OTHER